Literature DB >> 25030194

Thalassemias and hemoglobinopathies in Turkey.

Duran Canatan1.   

Abstract

Thalassemias and hemoglobinopathies are a serious health problem in Turkey. There is a 70-year history of thalassemia in Turkey. The first patient with β-thalassemia major (β-TM) was reported in 1941. The first clinical and hematological studies were published by Aksoy in 1958. The overall incidence of β-thalassemia (β-thal) was reported by Çavdar and Arcasoy to be 2.1% in 1971. Important steps such as written regulations, education and prevention campaigns, have been taken to prevent thalassemia in Turkey by the Ministry of Health (MOH), the Turkish National Hemoglobinopathy Council (TNHC) and the Thalassemia Federation of Turkey (TFT) since 2000. A national hemoglobinopathy prevention program was started in provinces with a high prevalence by the MOH in 2003. While the percentage of premarital screening test was 30.0% of all couples in 2003, it reached 86.0% in 2013. While the number of newborn with thalassemias and hemoglobinopathies was 272 in 2002, it had dropped to 25 in 2010. There has been a 90.0% reduction of affected births in the last 10 years.

Entities:  

Keywords:  Education; Turkey; hemoglobinopathies; premarital screening; prevention; thalassemia

Mesh:

Year:  2014        PMID: 25030194     DOI: 10.3109/03630269.2014.938163

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  6 in total

Review 1.  β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint.

Authors:  Vincenzo De Sanctis; Christos Kattamis; Duran Canatan; Ashraf T Soliman; Heba Elsedfy; Mehran Karimi; Shahina Daar; Yasser Wali; Mohamed Yassin; Nada Soliman; Praveen Sobti; Soad Al Jaouni; Mohamed El Kholy; Bernadette Fiscina; Michael Angastiniotis
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-02-20       Impact factor: 2.576

2.  A National Registry of Thalassemia in Turkey: Demographic and Disease Characteristics of Patients, Achievements, and Challenges in Prevention.

Authors:  Yeşim Aydınok; Yeşim Oymak; Berna Atabay; Gönül Aydoğan; Akif Yeşilipek; Selma Ünal; Yurdanur Kılınç; Banu Oflaz; Mehmet Akın; Canan Vergin; Melike Sezgin Evim; Ümran Çalışkan; Şule Ünal; Ali Bay; Elif Kazancı; Talia İleri; Didem Atay; Türkan Patıroğlu; Selda Kahraman; Murat Söker; Mediha Akcan; Aydan Akdeniz; Mustafa Büyükavcı; Güçhan Alanoğlu; Özcan Bör; Nur Soyer; Nihal Özdemir Karadaş; Ezgi Uysalol; Meral Türker; Arzu Akçay; Süheyla Ocak; Adalet Meral Güneş; Hüseyin Tokgöz; Elif Ünal; Naci Tiftik; Zeynep Karakaş
Journal:  Turk J Haematol       Date:  2017-04-13       Impact factor: 1.831

3.  The medical concerns of patients with thalassemias at the time of COVID-19 outbreak: The personal experience and the international recommendations.

Authors:  Duran Canatan; Vincenzo De Sanctis
Journal:  Acta Biomed       Date:  2020-05-11

4.  Awareness Among Educated and Uneducated Parents of Beta-Thalassemia Major Patients About Antenatal Screening.

Authors:  Lal Muhammad; Khawaja Kamran Wajid; Inayatullah Afridi; Sami Ullah; Afzal Khan; Amir Muhammad
Journal:  Cureus       Date:  2022-08-29

5.  Observed and expected frequencies of structural hemoglobin variants in newborn screening surveys in Africa and the Middle East: deviations from Hardy-Weinberg equilibrium.

Authors:  Frédéric B Piel; Thomas V Adamkiewicz; Djesika Amendah; Thomas N Williams; Sunetra Gupta; Scott D Grosse
Journal:  Genet Med       Date:  2015-12-03       Impact factor: 8.822

6.  A Novel Technique of Spectral Discrimination of Variants of Sickle Cell Anemia.

Authors:  Vadivel Masilamani; Sandanasamy Devanesan; Fatma AlQathani; Mashael AlShebly; Hebatullah Hassan Daban; Duran Canatan; Karim Farhat; Mansour Jabry; Mohamad S AlSalhi
Journal:  Dis Markers       Date:  2018-08-27       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.